Hemab Aps
Clinical trials sponsored by Hemab Aps, explained in plain language.
-
New drug trial aims to reduce bleeding in blood disorder patients
Disease control Recruiting nowThis early-stage study is testing a new drug called HMB-002 for adults with Von Willebrand Disease, a genetic bleeding disorder. Researchers want to see if the drug is safe, how it works in the body, and if it can reduce how often people experience bleeding episodes. The study wi…
Phase: PHASE1, PHASE2 • Sponsor: Hemab ApS • Aim: Disease control
Last updated Apr 02, 2026 06:42 UTC
-
New drug tested for rare bleeding disorder
Disease control Recruiting nowThis study is testing a single dose of an experimental drug called sutacimig in adults with severe congenital Factor VII deficiency, a rare bleeding disorder. The main goals are to check if the drug is safe and to see how the body processes it. Researchers will also measure if it…
Phase: PHASE2 • Sponsor: Hemab ApS • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Scientists track bleeds in rare blood disorder
Knowledge-focused Recruiting nowThis study aims to collect detailed information about how often people with Von Willebrand Disease (VWD) experience bleeding, how it affects their lives, and what treatments they use. Researchers will follow about 200 participants for 4 to 12 months, checking in regularly to trac…
Sponsor: Hemab ApS • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:09 UTC